BCL2A1 and melanoma: Apoptotic resistance in melanoma is thought to act via Bfl-1 (Hind et al., 2015), and likewise in glioblastoma via Bcl-2 (Weller et al., 1995) and Bcl-xL (Nagane et al., 2000).